Results 171 to 180 of about 75,481 (297)

Functional reassessment of extended splice region variants in MYO7A with hearing loss and Usher syndrome

The Journal of Pathology, Volume 269, Issue 2, Page 222-231, June 2026.
Abstract MYO7A is a causal gene, underlying Usher syndrome type 1B (USH1B) and both autosomal recessive (DFNB2) and dominant (DFNA11) non‐syndromic hearing loss. Despite the large number of reported MYO7A variants (over 2,200), variants located in an extended splice region remain difficult to interpret and are often classified as variants of uncertain ...
Tao Shi, Yu Huang, Xiaohuan Su, Lisheng Yu, Yixin Zhao, Jing Cheng   +5 more
wiley   +1 more source

Association between Vitamin D Level and Sensorineural Hearing Loss in Adults: Systematic Review and Meta-Analysis. [PDF]

Food Sci Nutr
Mohmed AMA, Elawad TOM, Mohammed AAEA, MohamedSalih T, Elbadawi MH, Alslawy YMA.   +5 more
europepmc   +1 more source

Feasibility of Minimally Invasive Robot‐Assisted Retrofacial Access to the Stapedius Muscle for Applications in Objective Cochlear Implant Fitting: A Cadaveric Study

The International Journal of Medical Robotics and Computer Assisted Surgery, Volume 22, Issue 3, June 2026.
ABSTRACT Background Accurate setting of maximum comfort levels (MCL) during cochlear implant (CI) fitting is essential but subjective, especially in non‐cooperative patients. The stapedius reflex (SR) correlates with the MCL and offers an objective measure.
Dirk Arnold, Francesca Maule, Pablo Galeazzi, Mohannad Al‐Qubaj, Orlando Guntinas‐Lichius   +4 more
wiley   +1 more source

Comparative Prognostic Analysis of Sudden Sensorineural Hearing Loss With Vertigo in Pediatric and Adult Patients. [PDF]

Laryngoscope Investig Otolaryngol
Shan C, Chen G, Li J, Guo F, Gao Y, Zhang J, Guan J, Wang D, Wang Q.   +8 more
europepmc   +1 more source

‘Do You Tell Them Not to Kiss Their Child?’ Implementing Congenital Cytomegalovirus Prevention Guidelines in General Practice: A Qualitative Study

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.
ABSTRACT Congenital cytomegalovirus (CMV) is a known cause of childhood‐onset disability. Australian guidelines recommend all pregnant women be informed about CMV risk‐reduction strategies. We conducted semi‐structured interviews with six Australian General Practitioners (GPs) who had completed a CMV eLearning module to explore their education ...
Natalia Rode, Hayley Smithers‐Sheedy, Kath Swinburn, Tanya Tripathi, Emma Waight, Lisa Hui   +5 more
wiley   +1 more source

Large Vestibular Aqueduct Syndrome Causing Progressive Hearing Loss in Childhood Article

Pakistan Journal of Medicine and Dentistry
Background: Sensorineural hearing loss in adults is commonly associated with aging, trauma or autoimmune disease. In children, however, sensorineural hearing loss can also be due to genetic causes, leading to malformation of internal ear structures ...
Salman Baig, Sana Ansari, Nash Patel, Nial Considine   +3 more
doaj  

Serum sCD163 indicates disease severity and prognosis in sudden sensorineural hearing loss. [PDF]

Mol Med
Xu T, Miao H, Xie B.
europepmc   +1 more source

Modelling Maternal Cytomegalovirus Seroprevalence in Australia Using Maternal Country of Birth: Implications for Antenatal Screening

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.
ABSTRACT Background Cytomegalovirus (CMV) is the most common congenital infection and a leading preventable cause of neurodevelopmental disability. Contemporary maternal CMV seroprevalence estimates are needed to inform antenatal screening policy in Australia.
Melvin Barrientos Marzan, Tanya Tripathi, Liv Dumville, Jo Watson, Natasha Holmes, Lisa Hui   +5 more
wiley   +1 more source

Neurobrucellosis: An Uncommon but Important Cause of Sensorineural Hearing Loss: a case report. [PDF]

J Otol
Messaoudi K, Yacine Mohamed Cherif W.
europepmc   +1 more source

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4975-4990, June 2026.
ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna, Carlos Mena‐Hurtado, Victoria Divino, Zhenxiang Zhao, Yan Chen, Joanna Boland, Jinlin Song, Andrea Traina, Kerem Ozer, Filip K. Knop, Kim G. Smolderen   +10 more
wiley   +1 more source